The Global 3D Bio-Printing Market is expected to grow at an approximate CAGR of 25% during the forecast period 2018-2023.
3D bio-printing is used to identify key compositional and architectural elements of a target tissue. This elements are used to create a design that is utilized by a bio-printer to generate that tissue in a laboratory environment. 3D Bioprinting has wide range of applications in the field of medicine, engineering, education, and others. Major factor driving the market is use of3D bio-printing to regenerative medicine addressing need for tissues and organs suitable for transplantation. Further, healthcare expenditure and research and development activities in 3D Bioprinting also influence the market growth.
North American 3D Bioprinting is the largest across the globe and is driven by increasing number of organ transplantation procedures, rising prevalence of chronic disorder such as liver failure, cardiovascular disorders, and others and growing adoption of 3D Bioprinting. Moreover, growing awareness about new technologies and needs organ transplantation at the end stage are also major factors affecting the market growth. The 3D Bioprinting market is exhibits growth due to developed healthcare infrastructure in the U.S. and presence of key players in the market. European 3D Bioprinting market also shows positive growth with rising government support for clinical trials and availability of funds for research. Focus on the applications of 3D Bioprinting in healthcare and overall development in the market are the major factors for the growth of the market. The market is led by Germany followed by France and U.K.
3D Bioprinting Market – Competitive Analysis & News
In 3D Bioprinting, significant increase in the number of the companies offering various products including number of healthcare IT solutions leads rising emphasis on use of information technology for healthcare management. Product launch, mergers, acquisition and collaboration are major strategic approaches of these players to achieve growth in the market.
Organovo Holdings, Inc.
The company use 3D Bioprinting technology to create functional 3D human tissues for medical research, surgical, and therapeutic applications. It product “ExVive” is the 3D bioprinted human tissues, that is used in Organomics- the study of living organs in-vitro. Another product, NovoGen Bioprinter platform manufactured by the company is used for translating tissue specific geometries and cellular components.
In December, 2017, the company was granted orphan drug designation for the treatment of alpha-1 antitrypsin deficiency (“A1AT”) with its 3D bioprinted liver therapeutic tissue by the U.S. Food and Drug Administration (FDA).
Get Sample Report @ https://www.marketresearchfuture.com/sample_request/869 .
Materialise is one of the major players in the market. The company undertakes 3D printing of anatomical models and offers 3D bioprinters.
In June 2017, Materialise improved 3D imaging and printing- clinical trials conducted in the U.S.
In March 2017, Materialise declared FDA clearance for its 3D-printed patient-specific radius and ulna osteotomy guides for children. In May 2017, the company announced it would start the production of 3D bioprinter using technology-HP Jet Fusion 3D 4200.
3D Bioprinting Market – Key Players
There are some of the key players for the global 3D bio-printing market: ORGANOVO HOLDINGS, INC. (U.S.), CELLINK AB (Sweden), Bio3D Technologies (Singapore), Aspect Biosystems Ltd. (Canada), Stratasys Ltd. (U.S.), Materialise (U.S.), FATHOM (U.S.), Allevi (U.S.), ENVISIONTEC, INC. (Germany), Nano3D Biosciences, Inc.(U.S.), Cyfuse Biomedical K.K. (Tokyo), 3Dynamic Systems Ltd. (U.K), REGENHU (Switzerland), Poietis (France), and others.
3D Bioprinting Market – Segmentation
The global 3D bio-printing market is segmented on the basis of technology, material, application, and end users.
On the basis of the technology, the market is segmented into electron beam melting, laser beam melting, droplet disposition, syringe extrusion, magnetic levitation, and others. The laser beam melting segment is sub segmented into photo polymerization, stereo lithography, two-photon polymerization, and others. The droplet disposition segment is sub segmented into inkjet printing, fused disposition methods, multi-phase jet solidification, and others.
On the basis of the material, the market is segmented into cells, hydrogels, extracellular matrices, fibrinogen, alginate, and others.
On the basis of the application, the market is segmented into clinical, research, and others. The clinical segment is sub segmented into tissue transplantation, bone grafts, vascular grafts, wound care, and others. The wound care segment, by application, is further segmented into acute wounds, chronic wounds, hernia repair, and others. The research segment is sub-segmented into regenerative medicine, personalized healthcare, 3D cell culture, and others.
On the basis of the end users, the market is segmented into pharmaceutical & biotechnology companies, research organization, academic institutes, and others.
To Know More Enquire @https://www.marketresearchfuture.com/enquiry/869 .
Major Table of Content
1 Report Prologue
2.2 Scope of the Study
2.2.1 Research Objective
2.3 Market Structure
2.4. Market Segmentation
3 Research Methodology
3.1 Research Process
3.2 Primary Research
3.3 Secondary Research
3.4 Market Size Estimation
3.5 Forecast Model
4 Market Dynamics
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.
Company Name: Market Research Future
Contact Person: Abhishek Sawant
Email: Send Email
Phone: +1 646 845 9312
Address:Market Research Future Office No. 528, Amanora Chambers Magarpatta Road, Hadapsar